In the first of three sessions, panelists with experience with population genetic screening programs will discuss issues that have arisen with existing screening programs. Topics may include ethical and equity considerations of informed consent, defining utility, selecting genes of interest, and managing downstream care. Recognizing that many people in the audience will also have relevant experience, everyone will be invited to share their experiences and concerns through live discussion with the panelists and through an online whiteboard.
ELSIcon2022 • Paper • May 27, 2022
Sara Watson, Karen Meagher
ELSIcon2022 • Flash • May 31, 2022
Sheethal Jose, Gail Geller, Juli Bollinger, Jeffrey Kahn, Brian Garibaldi
ELSIcon2022 • Paper • May 31, 2022
Rebecca Mueller
ELSIcon2022 • Paper • May 31, 2022
Kate Saylor
ELSIcon2022 • Paper • June 1, 2022
Aaron Goldenberg, Beth Tarini, Natasha Bonhomme, Amy Gaviglio
ELSIcon2022 • Paper • June 1, 2022
Jonathan Kahn
ELSIcon2022 • Networking Session • June 1, 2022
Kimberly Foss, Kate Saylor